Publications by authors named "Minglai Zhao"
Article Synopsis
- Cell replacement therapy shows promise for treating Parkinson's disease, but faces challenges before it can be a practical treatment option.
- Key barriers include developing safe surgical procedures, determining effective medication protocols for patients, and ensuring the longevity and integration of grafts.
- This review outlines the current state of cell therapy for Parkinson’s disease, focusing on essential requirements to help guide its development and clinical application.
Podocyte injury is the hallmark of proteinuric glomerular diseases. Notch3 is neo-activated simultaneously in damaged podocytes and podocyte's progenitor cells of FSGS, indicating a unique role of Notch3. We previously showed that activation of cAMP-PKA pathway alleviated podocyte injury possibly via inhibiting Notch3 expression.
View Article and Find Full Text PDF